BR0012992A - Bifidobactérias que previnem a diarréia causada por bactérias patogênicas - Google Patents

Bifidobactérias que previnem a diarréia causada por bactérias patogênicas

Info

Publication number
BR0012992A
BR0012992A BR0012992-5A BR0012992A BR0012992A BR 0012992 A BR0012992 A BR 0012992A BR 0012992 A BR0012992 A BR 0012992A BR 0012992 A BR0012992 A BR 0012992A
Authority
BR
Brazil
Prior art keywords
pathogenic bacteria
bifidobacteria
diarrhea caused
prevent diarrhea
present
Prior art date
Application number
BR0012992-5A
Other languages
English (en)
Inventor
Jean-Richard Neeser
Roberto Reniero
Florence Rochat
Alain Servin
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0012992A publication Critical patent/BR0012992A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0323—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin using only lactic acid bacteria, e.g. Pediococcus and Leuconostoc species; Bifidobacteria; Microbial starters in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: "BIFIDOBACTéRIAS QUE PREVINEM A DIARRéIA CAUSADA POR BACTéRIAS PATOGêNICAS". A presente invenção refere-se a novos microorganismos do gênero Bifidobacterium, que são úteis para prevenir contra diarréia causada por bactérias patogênicas. Em particular, a presente invenção refere-se ao uso dos referidos microorganismos para a preparação de um suporte ingerível e a uma composição contendo o mesmo.
BR0012992-5A 1999-08-05 2000-07-26 Bifidobactérias que previnem a diarréia causada por bactérias patogênicas BR0012992A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99115502 1999-08-05
PCT/EP2000/007208 WO2001011015A1 (en) 1999-08-05 2000-07-26 New bifidobacteria preventing diarrhea caused by pathogenic bacteria

Publications (1)

Publication Number Publication Date
BR0012992A true BR0012992A (pt) 2002-05-07

Family

ID=8238733

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012992-5A BR0012992A (pt) 1999-08-05 2000-07-26 Bifidobactérias que previnem a diarréia causada por bactérias patogênicas

Country Status (12)

Country Link
US (2) US6926891B1 (pt)
EP (1) EP1206523B1 (pt)
CN (1) CN1186440C (pt)
AT (1) ATE425244T1 (pt)
AU (1) AU6160200A (pt)
BR (1) BR0012992A (pt)
CA (1) CA2380849C (pt)
DE (1) DE60041770D1 (pt)
ES (1) ES2321797T3 (pt)
HK (1) HK1046929A1 (pt)
TR (1) TR200200301T2 (pt)
WO (1) WO2001011015A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
EP1997880A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Breast milk bifidobacteria, compositions thereof, their use and a novel culture media to obtain them
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
US10798877B2 (en) 2011-05-05 2020-10-13 Steven J Terrell Apparatus for aerial tool configurations
US11382279B2 (en) 2011-05-05 2022-07-12 Steven J Terrell Apparatus for aerial tool configurations
US11690324B2 (en) 2011-05-05 2023-07-04 Steven J Terrell Apparatus for aerial tool configurations
US10492373B2 (en) 2011-05-05 2019-12-03 Steven J Terrell Apparatus for aerial tool configurations
US11330766B2 (en) 2011-05-05 2022-05-17 Steven J Terrell Apparatus for aerial tool configurations
US10492372B2 (en) 2011-05-05 2019-12-03 Steven J Terrell Apparatus for aerial tool configurations
EP2797426A1 (en) * 2011-12-29 2014-11-05 Hill's Pet Nutrition, Inc. Compositions and methods for modifying gastrointestinal flora
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
WO2016129863A1 (en) 2015-02-12 2016-08-18 Samsung Electronics Co., Ltd. Payment processing method and electronic device supporting the same
KR102460459B1 (ko) 2015-02-27 2022-10-28 삼성전자주식회사 전자 장치를 이용한 카드 서비스 방법 및 장치
US10193700B2 (en) 2015-02-27 2019-01-29 Samsung Electronics Co., Ltd. Trust-zone-based end-to-end security
WO2016137277A1 (en) 2015-02-27 2016-09-01 Samsung Electronics Co., Ltd. Electronic device providing electronic payment function and operating method thereof
US10846696B2 (en) 2015-08-24 2020-11-24 Samsung Electronics Co., Ltd. Apparatus and method for trusted execution environment based secure payment transactions
US10699274B2 (en) 2015-08-24 2020-06-30 Samsung Electronics Co., Ltd. Apparatus and method for secure electronic payment
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
JP7811843B2 (ja) 2018-07-19 2026-02-06 ペンデュラム セラピューティクス， インコーポレイテッド 微生物生着のための方法および組成物
JP7828296B2 (ja) * 2020-05-14 2026-03-11 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生細菌を使用する方法及び組成物
CN114747534B (zh) * 2021-12-02 2023-04-18 中国农业大学 腹泻性大肠杆菌感染动物模型的构建方法及其应用
CN116121119B (zh) * 2022-11-30 2024-01-26 天津小薇生物科技有限公司 一种治疗腹泻的长双歧杆菌bc012及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172245T1 (de) 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
DK0577903T3 (da) 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica

Also Published As

Publication number Publication date
EP1206523A1 (en) 2002-05-22
ES2321797T3 (es) 2009-06-12
DE60041770D1 (de) 2009-04-23
CA2380849A1 (en) 2001-02-15
TR200200301T2 (tr) 2004-12-21
WO2001011015A1 (en) 2001-02-15
ATE425244T1 (de) 2009-03-15
AU6160200A (en) 2001-03-05
US7767430B2 (en) 2010-08-03
EP1206523B1 (en) 2009-03-11
CN1186440C (zh) 2005-01-26
CN1369005A (zh) 2002-09-11
HK1046929A1 (zh) 2003-01-30
US6926891B1 (en) 2005-08-09
US20050260170A1 (en) 2005-11-24
CA2380849C (en) 2010-06-29

Similar Documents

Publication Publication Date Title
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
MY125941A (en) New lactobacillus strains preventing diarrhoea caused by pathogenic bacteria
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
IL137093A0 (en) Methods of inactivating bacteria including bacterial spores
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
BG103664A (en) Pharmaceutical forms containing ammoxycillin and clavulanate
BR0008920A (pt) Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
NO20040347L (no) Fast preparat inneholdende Bacillus-type ikke-patogene bakteriesporer
TR200200300T2 (tr) İshali önlemeye elverişli bifidobakteriler.
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
AR021159A1 (es) Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina
ES2191625T3 (es) Composicion oral que contiene perlita.
ATE197645T1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
GB9923858D0 (en) Antimicrobial compositions
IL105205A0 (en) Microorganisms,and their isolation and use
AU7655600A (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
KR950018031A (ko) 복합 올리고당 조성물
BR0115182A (pt) Composição de substância carreadora de produtos à base de papaìna e hialuronidase
KR930005623A (ko) 복합 올리고당 조성물

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: O DEPOSITANTE DEVERA APRESENTAR A PETICAO DEVIDA PARA O CUMPRIMENTO DESTA EXIGENCIA EM ATE 60 (SESSENTA) DIAS, CONTADOS A PARTIR DA DATA DE PUBLICACAO NA RPI, DE ACORDO COM O ART. 34 (II) DA LPI PARA QUE SE DE INICIO AO EXAME TECNICO DO PEDIDO.

B15V Prolongation of time limit allowed

Free format text: DEVOLUCAO DE PRAZO CONCEDIDA - RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 15 DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OART .8O COMBINADO COM ART. 13 DA LPI .

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time